Author:
Raoul Jean-Luc,Edeline Julien
Reference10 articles.
1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009
3. Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design;Llovet;Clin Cancer Res,2014
4. Molecular therapies and precision medicine for hepatocellular carcinoma;Llovet;Nat Rev Clin Oncol,2018
5. Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial;Qin;Lancet Oncol,2020
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献